LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
MDA-MB-231 Neratinib
0.37
uM
LJP5
 2
A16
 72
hr
 868 2104 3486 0.6035 0.4720
MDA-MB-231 Neratinib
0.37
uM
LJP5
 3
A16
 72
hr
 868 2253 3486 0.6462 0.5289
MDA-MB-231 Nilotinib
0.37
uM
LJP5
 1
N16
 72
hr
 868 2433 3486 0.6979 0.5977
MDA-MB-231 Nilotinib
0.37
uM
LJP5
 2
N16
 72
hr
 868 2849 3486 0.8172 0.7566
MDA-MB-231 Nilotinib
0.37
uM
LJP5
 3
N16
 72
hr
 868 2569 3486 0.7369 0.6496
MDA-MB-231 Nintedanib
0.37
uM
LJP6
 1
H04
 72
hr
 868 3129 3486 0.8975 0.8635
MDA-MB-231 Nintedanib
0.37
uM
LJP6
 2
H04
 72
hr
 868 3753 3486 1.0765 1.1018
MDA-MB-231 Nintedanib
0.37
uM
LJP6
 3
H04
 72
hr
 868 3628 3486 1.0406 1.0541
MDA-MB-231 NU7441
0.37
uM
LJP5
 1
C10
 72
hr
 868 2776 3486 0.7962 0.7287
MDA-MB-231 NU7441
0.37
uM
LJP5
 2
C10
 72
hr
 868 2539 3486 0.7283 0.6382
MDA-MB-231 NU7441
0.37
uM
LJP5
 3
C10
 72
hr
 868 3086 3486 0.8852 0.8471
MDA-MB-231 Dactolisib
0.37
uM
LJP5
 1
M16
 72
hr
 868 1447 3486 0.4150 0.2211
MDA-MB-231 Dactolisib
0.37
uM
LJP5
 2
M16
 72
hr
 868 1735 3486 0.4977 0.3311
MDA-MB-231 Dactolisib
0.37
uM
LJP5
 3
M16
 72
hr
 868 1586 3486 0.4549 0.2742
MDA-MB-231 NVP-TAE684
0.37
uM
LJP6
 1
K16
 72
hr
 868 2589 3486 0.7426 0.6573
MDA-MB-231 NVP-TAE684
0.37
uM
LJP6
 2
K16
 72
hr
 868 2661 3486 0.7633 0.6848
MDA-MB-231 NVP-TAE684
0.37
uM
LJP6
 3
K16
 72
hr
 868 2521 3486 0.7231 0.6313
MDA-MB-231 Palbociclib
0.37
uM
LJP6
 1
E16
 72
hr
 868 2125 3486 0.6095 0.4800
MDA-MB-231 Palbociclib
0.37
uM
LJP6
 2
E16
 72
hr
 868 1868 3486 0.5358 0.3819
MDA-MB-231 Palbociclib
0.37
uM
LJP6
 3
E16
 72
hr
 868 1931 3486 0.5539 0.4060
MDA-MB-231 PD0325901
0.37
uM
LJP5
 1
C04
 72
hr
 868 1456 3486 0.4176 0.2245
MDA-MB-231 PD0325901
0.37
uM
LJP5
 2
C04
 72
hr
 868 1668 3486 0.4784 0.3055
MDA-MB-231 PD0325901
0.37
uM
LJP5
 3
C04
 72
hr
 868 1295 3486 0.3714 0.1630
MDA-MB-231 PD0325901
0.37
uM
LJP6
 1
E04
 72
hr
 868 1314 3486 0.3769 0.1703
MDA-MB-231 PD0325901
0.37
uM
LJP6
 2
E04
 72
hr
 868 1496 3486 0.4291 0.2398